FDA delays substantive response to NMN petition

Citing “competing agency priorities,” the Food and Drug Administration said in a recent letter it has not reached a substantive decision on a citizen petition pertaining to NMN in dietary supplement products.

Related Keywords

United States ,China ,Chinese ,Cara Welch ,Alliance For Natural Health United States ,Drug Administration ,Syncozymes Shanghai Co ,Office Of Dietary Supplement Programs ,Natural Products Association ,Metro International Biotech ,Dietary Supplement Health ,Natural Health United States ,Nicotinamide Mononucleotide ,Dietary Supplement Programs ,Natural Health United ,Metro International ,Education Act ,Market Reports World ,Natural Products ,